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a b s t r a c t
Objective: Nonprescription or over-the-counter (OTC) medications play a crucial role in a
patient’s ability to make choices to manage his or her own health care. Often these nonpre-
scription choices are unknown to health care practitioners and thus are often not included as
part of patients’ health records. The exclusion of these therapies can pose risks to patient
safety. There is a significant need to address the capture of OTC medication use in both the
physician and pharmacy electronic health records (EHRs) and during the practitionerepatient
medication history and reconciliation process.
Data sources: On October 26, 2016, the National Association of Chain Drug Stores Foundation
hosted a forum for a select group of health care industry professionals to work on a series of
recommendations to improve the documentation of OTC medication use by patients. This
diverse group of more than a dozen stakeholders included community pharmacy leaders from
multiple chain pharmacies, pharmacy system vendors, e-prescribing vendors, health infor-
mation technology experts, and multiple industry representatives, including individuals from
the public sector. This commentary is a summary of the insights and suggestions where the
group was in general agreement.
Summary: Successful OTC medication EHR integration will require system-level buy-in across
multiple layers of the health care industry to improve patient safety. Forum participants
suggested incremental steps that could be taken by multiple stakeholders to lay the founda-
tion for integration within an appropriate regulatory structure.
Conclusion: Based on the results of the stakeholder forum, an agreement formed around one
approach that the group supported as feasible: the creation of a consistent and uniform iden-
tification method for OTC medications in cooperation with government regulatory authorities.
© 2018 The Author. Published by Elsevier Inc. on behalf of the American Pharmacists
Association®. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
The purpose of this commentary is to provide a summary of
insights and suggestions by key community pharmacy
industry stakeholders (Table 1) who were asked to evaluate
the technological capability and opportunities to incorporate
over-the-counter (OTC) medications into comprehensive
electronic health records (EHRs).
Goals of the forum
The stated goals of the forum were: (1) to provide an
environmental assessment of opportunities where OTC
medication information can be collected beginning with point
of sale; (2) to explain the role of technology in instances where
OTC medications are documented or omitted in the normal
process of care, including at the pharmacy; (3) to discuss the
feasibility of OTC medications being included in the EHR
through interoperability between physician and pharmacy
record systems; and (4) to provide system-level recommen-
dations to begin collaboratively incorporating OTC medica-
tions into EHRs.
For the purposes of this commentary, EHRs, as defined by
the Centers for Medicare and Medicaid Services, are an
electronic version of a patient’s medical history that are
maintained by the provider over time and can include all the
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key administrative clinical data relevant to that person’s care
under a particular provider.1 Currently, community pharmacy
dispensing systems often do not collect OTC information, nor
do they communicate with physician office EHRs.
Overview of nonprescription drug use
OTC medications play a crucial role in our nation’s health
care system by increasing access to effective medications and
empowering individuals to make health care choices for
themselves and their families. A recent consumer survey
found that 89% of consumers value OTC medications as part of
their health care and 81% of U.S. adults use OTC medicines as a
first response to minor ailments.2 Furthermore, in a survey of
more than 500 health care practitioners, 89% of pediatricians
surveyed either recommended or had no reservations rec-
ommending OTC medications to their patients.3
Enhanced access to these medications empowers patients
to take an active role in their health and improves the health
care system overall. Taken correctly, OTC medications are safe,
affordable, and effective.
Patient safety and gaps in care
Although OTC medications improve the health of millions of
patients, risks due to inappropriate use can pose a substantial
risk to patient safety, including complications from drugedrug
interactions, accidental drug duplication, and unforeseen
drugedisease complications. The high prevalence of OTC
medication use means that these risks are not insignificant. For
example, in a survey of patients with heart failure, 88% reported
OTC medication use.4 The OTC medications used included
nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump
inhibitors, antacids, and decongestants. NSAIDs, in particular,
could have serious implications in patients with heart failure.
The risk of OTC medication interactions owing to lack of
documentation has been confirmed in multiple studies. In a
retrospective analysis of electronic patient health records in
Dutch community pharmacies, 44% did not accurately include
OTC medications.5 In another study, 60% of surveyed patients
were unaware of the risks associated with NSAID use, and 30%
thought that OTC medicines were safer because they were
available without a prescription.6 Lastly, in a retrospective EHR
chart review at a primary care center, pharmacists identified
that nearly 75% of EHR entries had at least 1 discrepancy, and
the omission of OTC medication use was the most common.7
Improved OTC documentation could reduce discrepancies to
affect patient care positively.
How prescription documentation differs from OTC
There are major differences in the way that EHRs document
prescription medications compared with OTC medications.
Currently, it is easier to capture prescription medication use
in EHRs because of electronic prescribing and the extensive in-
surance payment systems that exist to document and pay for
prescription medications. Pharmacy benefit managers, e-
prescribing systems, and pharmacy dispensing software must
tightly function to adequately complete the prescription drug
dispensing process. By contrast, most OTC medication trans-
actions occur at a retail location, often outside the pharmacy,
where a consumer does not use his or her health insurance but
pays outofpocket. Few, if any, systemsare inplace to capture this
OTC transaction information. Thus, OTCmedication safety alerts
andother prescribing information arenot as readilyaccessible to
prescribers and patients as their prescribed counterparts.
Because of these current challenges in documenting OTC
medications, most of them are simply input into EHRs by
providers as free-form text entries when conducting a medi-
cation history or medication reconciliation with the patient.
This type of documentation can inhibit the accurate and effi-
cient communication of OTC medication use across EHRs in
the future, leading to potential exclusion from the alert
screening process. Furthermore, lack of health information
technology interoperability between disparate data systems
limits exchange of data. EHR interoperability is a subject
beyond the scope of the forum discussion. However, efforts led
by the Office of the National Coordinator (ONC) will play a key
role in any future documentation and communication of OTC
medications, including the Pharmacist eCare Plan. Specific
features related to the documentation of OTC medications
within the IT construct were considered to help facilitate in-
clusion and implementation of health information technology
interoperability efforts in the future.
Existing identifiers: NDCs, UPCs, and SKUs
Forum stakeholders noted that OTC medications each
contain a National Drug Code (NDC), which is required for
registration with the U.S. Food and Drug Administration. Par-
ticipants suggested that the use of NDCs might offer the best
short-term solution for the identification of specific OTC
Key Points
Background:
 The purpose of this commentary is to provide a
summary of insights and suggestions by key com-
munity pharmacy industry stakeholders who were
asked to evaluate the technological capability and
opportunities to incorporate over-the-counter (OTC)
medications into comprehensive electronic health
records (EHRs).
Findings:
 There were 3 key points of agreement that shaped
the recommendations:
 General Agreement, Point 1: Effective documenta-
tion systems for OTC medications in EHRs may help
to provide patients and providers with the necessary
information to increase appropriate OTC use.
 General Agreement, Point 2: System-level buy-in
across multiple layers of the health care industry will
be required for successful OTC-EHR integration.
 General Agreement, Point 3: Incremental steps by
multiple stakeholders should be taken to lay the
foundation for OTC-EHR integration, provided it is
within an appropriate regulatory structure.
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medication products because of the prevalence of NDCs within
the existing regulatory structure.
Stakeholders noted that alternative solutions for identifi-
cation of OTC medications outside the NDCs are currently
being created in the private sector but shared that a lack of
consistency in labeling and drug information for OTC medi-
cations poses a significant impediment to their widespread
EHR adoption.
For example, unique product codes (UPCs) have a similar
number, which is assigned by the product manufacturer. In
some cases, the UPC is the NDC code with a 1 or 0 attached.
However, UPCs are not required to have the same component
consistency as an NDC code.
OTC medication products also contain an identification
code at each business for price scanning and inventory pur-
poses, commonly known as a stock keeping unit (SKU).
However, SKU purchase history and data are not currently tied
to any clinical data system, even within pharmacies.
Other technology-facilitated programs considered by
Forum participants:
 Loyalty Programs: Loyalty programs are comonly used by
retailers in marketing to offer deals and targeted adver-
tising. A customer’s shopping history could provide retail-
specific data on OTC purchases. However, stakeholders
noted that businesses might not be inclined to adapt their
existing programs to embrace the inclusion of EHR inte-
gration. In addition, many loyalty programs are household-,
not individual-based, making them less than ideal for
identifying patient-specific OTC medication use.
 Health Savings Accounts: Some employer-sponsored in-
surance plans offer federal Health Savings Accounts,
allowing employees to use before tax dollars to pay for
health care products not reimbursed by insurance,
including OTCmedications. This could serve some purposes
of data collection. However, this option would be limited
because Health Savings Accounts are only available to those
covered by employer-sponsored health insurance.
 Pharmacy Dispensing Software: Commercially available
pharmacy dispensing software can capture and record OTC
medication use. However,most information is limited to data
reported by the patient verbally during potential consulta-
tions or discussions between patient and pharmacistda
mere fraction of overall OTC use.
Challenges
Forum stakeholders agreed that for effective and accurate
documentation within an EHR, the following overarching
challenges must be addressed:
 Many Retailers: One of the top challenges was the avail-
ability of OTC medications through a vast array of retail
outlets. In addition to pharmacies, supermarkets, whole-
sale clubs, and online merchants, OTC medications are
available in places such as gas stations, convenience stores,
hotel gift shops, airport newspaper stands, and many
others. There are an estimated 750,000 total retail locations
in the United States.8 While convenient, this poses a major
challenge to EHR integration.
 Purchaser versus End User: Purchasers are not necessarily
end users. Purchase history of OTC drug products alone
does not necessarily describe individual OTC medication
use. In many cases, consumers can purchase medications
for someone within their family or can share their medi-
cines with another individual not in their home, such as a
neighbor, friend, or co-worker.
 Privacy: Effectively capturing OTCmedication datawith the
consumer’s active consent may require the health care
system to meet privacy expectations like those in place for
prescription medications. Stakeholders reinforced the
importance of consumer trust to adequately address pri-
vacy concerns.
While these challenges are mostly logistical, the stake-
holders of the conference offered a first-step consideration to
begin addressing a few specific disease states, such as diabetes
or cardiovascular disease where risks to patient safety are
greater than for others. Selectively targeting specific medical
conditions along with OTC medicines that contain warnings
related to use in individuals with that same medical condition
was considered a reasonable first step.
Patienteprovider interaction
The current primary documentation of OTC medication use
in the EHR still occurs as part of a one-on-one interaction with
a health care provider. Often, when patients are asked about
their medication use, they will defer to listing their prescrip-
tion medications and possibly daily OTC medications. Yet,
consumers use OTC medications far more frequently than they
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trips to purchase OTC medications over a 12-month period
compared with 3 visits to their physician over the same time
span.8 This fact alone lends perspective to the challenge of OTC
integration into EHRs.
Studies have shown that one method of improving medi-
cation record accuracy is to provide patients online access to
their data before medical visits.9 However, stakeholders
confirmed that inherent barriers exist when applying that
same approach to reporting OTC medication use.
Patient-driven solutions
Software systems known as applications or apps can collect,
document, and provide resources directly to a patient’s laptop
or mobile device, potentially enhancing patient understanding
and documentation of OTC medications. Current technology,
including scanning for QR codes or barcodes, could link to an
NDC and specific medication information for each OTC medi-
cation. However, the creation and widespread use of such
technology are in the early stages of development and
adoption.
Furthermore, stakeholders identified the need for patients
to be incentivized to report OTC medication use. To date, the
usefulness of patient-driven electronic personal health records
has been met with mixed results. One promising app was ul-
timately discontinued because of the inability to reach con-
sumers effectively. Major contributing factors included lack of
patient education, promoting patient usefulness, and encour-
aging trust from the user.10
Increasing patient awareness and education was consid-
ered outside the scope of the Forum discussion, but stake-
holders agreed that any efforts to create a consistent uniform
code for identification should take these considerations into
account.
Payer-driven solutions
One way that changes in health care provision can be
driven is by implementation of new, quality metrics. A per-
formance measure around OTC documentation in the EHR
could incentivize providers to improve collection of OTC uti-
lization during patient encounters.
Conclusion
The integration of OTC medications into patients’ EHRs is a
complex issue that has the potential to affect patient care
positively and to improve outcomes. Table 2 represents
stakeholders’ recommendations to work toward OTC medi-
cation EHR integration:
1. Create a consistent, uniform identification method for OTC
medications.
 Target a narrow set of high-priority health conditions and
related OTC medications as a starting place for uniform
identification.
 Enlist the participation of OTC manufacturers, the U.S.
Food and Drug Administration, and appropriate govern-
ment entities regarding the creation and consistent
execution of a uniform identification system.
 Create a publiceprivate collaboration to enhance
reporting of OTC medication specific information.
2. Anticipate the potential for future patient engagement
through patient-driven technologies, such as apps, by
building adaptability into data collection design.
A focus on standardized integration of OTC information for
new and changing products could potentially increase the
appropriate choice and use of OTC products for some in-
dividuals, allowing the basis by which they can be integrated
into pharmacists’ patient care process and team-based care.
Lastly, payers can create value for patients, providers, and
system vendors by aligning payments with developed quality
measures and incentivizing documentation of OTC medica-
tions in EHR systems.
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Table 2
Logic model: Progression concept for prescription and over-the-counter medical record integration
Strategy and activities Short-term outcomes Intermediate outcomes Long-term outcomes
Selectively targeting specific medical
conditions along with OTC medicines that
contain warnings related to use of the OTC
medicine in individuals with that same
medical condition. An example of this
would be CV disease and NSAIDs that
have CV-related warnings.
Increased industry awareness
of Rx/OTC EHR integration
approach and strategy for
achieving it






Engage manufacturers and FDA regarding the
creation of a uniform identification system.
Increased opportunities to
engage patients and providers
through technology
Create an industry and regulatory




Increased testing and use of
patient-driven innovations for
EHR integration (including the
Pharmacist eCare Plan)
Anticipate patient-driven technologies by
building adaptability into the data collection
design.
Abbreviations used: OCT, over-the-counter; CV, cardiovascular; NSAID, nonsteroidal anti-inflammatory drug; Rx, prescription; EHR, electronic health records;
FDA, U.S. Food and Drug Administration.




1. Electronic Health Records. Available at: https://www.cms.gov/Medicare/
E-Health/EHealthRecords/index.html. Accessed August 15, 2017.
2. StrategyOne. In: Your Health at Hand: Perceptions of over-the-counter
medicine in the U.S. 2010. Available at: http://www.yourhealthathand.org/
images/uploads/CHPA_YHH_Survey_062011.pdf. Accessed August 15, 2017.
3. IMS Na. Understanding Trust in OTCMedicines: Consumer and Healthcare
Provider Perspectives. Available at: http://www.yourhealthathand.org/
images/uploads/CHPA_OTC_Trust_Survey_White_Paper.pdf. Accessed
August 15, 2017.
4. Mattila M, Boehm L, Burke S, et al. Nonprescription medication use in
patients with heart failure: assessment methods, utilization patterns,
and discrepancies with medical records. J Card Fail. 2013;19(12):
811e815.
5. Floor-Schreudering A, Heringa M, Buurma H, Bouvy ML, De Smet PA.
Missed drug therapy alerts as a consequence of incomplete electronic
patient records in Dutch community pharmacies. Ann Pharmacother.
2013;47(10):1272e1279.
6. Abdolrasulnia M, Weichold N, Shewchuk R, et al. Agreement between
medical record documentation and patient-reported use of nonsteroidal
anti-inflammatory drugs. Am J Health Syst Pharm. 2006;63(8):744e747.
7. Stewart AL, Lynch KJ. Identifying discrepancies in electronic medical
records through pharmacist medication reconciliation. J Am Pharm Assoc
(2003). 2012;52(1):59e66.
8. Consumer Healthcare Products Association. Statistics on OTC Use.
Washington, DC: CHPA; 2014. Available at: https://www.chpa.org/
marketstats.aspx. Accessed August 15, 2017.
9. Dullabh PM, Sondheimer NK, Katsh E, Evans MA. How patients can
improve the accuracy of their medical records. EGEMS (Washington, DC).
2014;2(3):1080.
10. Spil T, Klein R. Personal Health Records Success: Why Google Health Failed
and What Does that Mean for Microsoft HealthVault?. Paper presented at:
2014 47th Hawaii International Conference on System Sciences. 2014.
Clark D. Kebodeaux, PharmD, BCACP, Clinical Assistant Professor, Department
of Pharmacy Practice and Science, University of Kentucky College of Pharmacy,
Lexington, KY
OTC EHR integration
SCIENCE AND PRACTICE
5
